Tapewire

Nasdaq · USD

INSM

INSMED Inc

Export transactions ↓
Tapewire entity
3174
SEC CIK
0001104506
Parsed reports
490

Last 12 months

Inside the activity.

0 purchase rows · 169 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 2025018
Jan 2026044
Feb 2026022
Mar 202608
Apr 2026010
May 2026019
Jun 2026013
Jul 202607
Aug 202604
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 29, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 220,564 $50.00 $11,028,200.00
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 14

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,481

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 220,564 shares sold at prices ranging from $50.00 to $50.08 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 29, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 32,156 $17.07 $548,902.92
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 12

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 358,769

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 29, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 20,111 $26.43 $531,533.73
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 10

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 323,159

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 29, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 39,446 $26.46 $1,043,741.16
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 8

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 299,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 29, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 25,046 $34.03 $852,315.38
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 6

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 256,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 29, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 27,074 $24.70 $668,727.80
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 4

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 228,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 29, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 76,731 $28.88 $2,215,991.28
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 197,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:46 UTC
Wise John DraytonChief Commercial Officer
Exercise / conversionStock Option (right to buy) · Derivative 6,250 $0.00 Strike: $12.58 $0.00
Disclosure

SEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · derivative · entry 4

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires 2024-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:46 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 6,250 $50.00 $312,500.00
Disclosure

SEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,657

F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:46 UTC
Wise John DraytonChief Commercial Officer
Exercise / conversionCommon Stock 6,250 $12.58 $78,625.00
Disclosure

SEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,907

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:46 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 1,602 $48.95 $78,417.90
Disclosure

SEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,657

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 14,810 $0.00 Strike: $13.67 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 11

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,810 shares

Expires 2027-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,470 $0.00 Strike: $11.38 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 10

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,470 shares

Expires 2026-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,691 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 9

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,691 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.16 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 8

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2026-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 7,000 $0.00 Strike: $16.07 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 7

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2025-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 44,722 $49.53 $2,215,080.66
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 6

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,828

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionCommon Stock 14,810 $13.67 $202,452.70
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 5

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionCommon Stock 3,470 $11.38 $39,488.60
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 4

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionCommon Stock 3,691 $10.85 $40,047.35
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 3

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,270

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionCommon Stock 10,000 $16.16 $161,600.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionCommon Stock 7,000 $16.07 $112,490.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:44 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
Exercise / conversionStock Option (right to buy) · Derivative 27,500 $0.00 Strike: $12.58 $0.00
Disclosure

SEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · derivative · entry 3

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,500 shares

Expires 2024-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:44 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 27,500 $49.53 $1,362,075.00
Disclosure

SEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · nonDerivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,760

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:44 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
Exercise / conversionCommon Stock 27,500 $12.58 $345,950.00
Disclosure

SEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,260

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:43 UTC
Flammer Martina M.D.Chief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 103,806 $0.00 Strike: $23.66 $0.00
Disclosure

SEC source: 0001628280-24-025890 · wk-form4_1717105381.xml · derivative · entry 5

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,874

Underlying: Common Stock · 103,806 shares

Expires 2030-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:43 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 103,806 $49.62 $5,150,853.72
Disclosure

SEC source: 0001628280-24-025890 · wk-form4_1717105381.xml · nonDerivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,134

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 103,806 shares sold at prices ranging from $49.53 to $50.00 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:43 UTC
Flammer Martina M.D.Chief Medical Officer
Exercise / conversionCommon Stock 103,806 $23.66 $2,456,049.96
Disclosure

SEC source: 0001628280-24-025890 · wk-form4_1717105381.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 209,940

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,454 $0.00 Strike: $17.07 $0.00
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 25

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,506

Underlying: Common Stock · 3,454 shares

Expires 2032-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · derivative.exercise_date: The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,454 $0.00 Strike: $26.43 $0.00
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 23

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,386

Underlying: Common Stock · 3,454 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · derivative.exercise_date: The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,454 $0.00 Strike: $26.46 $0.00
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 21

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,186

Underlying: Common Stock · 3,454 shares

Expires 2031-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · derivative.exercise_date: The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,454 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 19

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,146

Underlying: Common Stock · 3,454 shares

Expires 2031-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · derivative.exercise_date: The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,454 $0.00 Strike: $24.70 $0.00
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 17

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,436

Underlying: Common Stock · 3,454 shares

Expires 2030-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,454 $0.00 Strike: $28.88 $0.00
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 15

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,186

Underlying: Common Stock · 3,454 shares

Expires 2030-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 20,724 $50.01 $1,036,407.24
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 13

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 338,045

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 20,724 shares sold at prices ranging from $50.00 to $50.07 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 3,454 $17.07 $58,959.78
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 11

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 326,613

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 3,454 $26.43 $91,289.22
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 9

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 303,048

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 3,454 $26.46 $91,392.84
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 7

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 260,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 3,454 $34.03 $117,539.62
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 5

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 231,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 3,454 $24.70 $85,313.80
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 3

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 201,120

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:41 UTC
Bonstein SaraChief Financial Officer
Exercise / conversionCommon Stock 3,454 $28.88 $99,751.52
Disclosure

SEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 17, 2024 Filed May 17, 2024 20:16 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 4,642 $25.09 $116,467.78
Disclosure

SEC source: 0001628280-24-024066 · wk-form4_1715977000.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,134

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 17, 2024 Filed May 17, 2024 20:15 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 5,945 $25.09 $149,160.05
Disclosure

SEC source: 0001628280-24-024060 · wk-form4_1715976900.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 149,275

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:39 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 5,088 $25.47 $129,591.36
Disclosure

SEC source: 0001628280-24-023613 · wk-form4_1715805527.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,259

F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 5,088 shares sold at prices ranging from $25.45 to $25.50 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:37 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 5,093 $25.40 $129,362.20
Disclosure

SEC source: 0001628280-24-023608 · wk-form4_1715805452.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,579

F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 5,093 shares sold at prices ranging from $25.38 to $25.42 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:36 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 6,508 $25.53 $166,149.24
Disclosure

SEC source: 0001628280-24-023605 · wk-form4_1715805404.xml · nonDerivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,760

F4 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F5 · price: This is the weighted average sales price representing 6,508 shares sold at prices ranging from $25.50 to $25.55 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:34 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 22,198 $25.52 $566,492.96
Disclosure

SEC source: 0001628280-24-023600 · wk-form4_1715805282.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,125

F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 22,198 shares sold at prices ranging from $25.41 to $25.67 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:33 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 10,640 $25.47 $271,000.80
Disclosure

SEC source: 0001628280-24-023598 · wk-form4_1715805215.xml · nonDerivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,776

F3 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 10,640 shares sold at prices ranging from $25.42 to $25.52 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:32 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 11,088 $25.32 $280,748.16
Disclosure

SEC source: 0001628280-24-023591 · wk-form4_1715805145.xml · nonDerivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,481

F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 11,088 shares sold at prices ranging from $25.28 to $25.36 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:31 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 7,857 $25.50 $200,353.50
Disclosure

SEC source: 0001628280-24-023589 · wk-form4_1715805079.xml · nonDerivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,220

F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 7,857 shares sold at prices ranging from $25.48 to $25.57 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.